Leadership

Board of Directors

Nassos Michas, Chairman.  CEO, Stonington Partners, LLC, former President and CEO Weiss Peck and Greer,  former Chairman Merrill Lynch Banks

Nicholas Bacopoulos, Ph.D.,  President & CEO Mersana Therapeutics, formerly President & CEO, Aton Pharmaceuticals, former President/CSO OSI Pharmaceuticals

Harry H. Penner, Jr., J.D.,  Chairman & CEO Nascent Bioscience, formerly President, CEO and Vice Chairman, Marinus Pharmaceuticals, former President CEO & Vice Chair, Neurogen

Alex Makriyannis, Ph.D., Behrakis Professor of Pharmaceutical Biotechnology, Director of the Center for Drug Discovery, Northeastern University, formerly Distinguished Professor of Medicinal Chemistry, Pharmacology, Molecular and Cell Biology, University of Connecticut, and Director, Center for Drug Discovery, University of Connecticut.

Scientific Advisory Board

Alex Makriyannis, Ph.D., (See above)

Frank Porreca, Ph.D., Professor of Pharmacology, Department of Pharmacology, University of Arizona

Henry Esber, Ph.D., VP & Chief Business Development Officer Bio-Quant, formerly Executive Director Business Development Primedica Corporation, Affiliate professor, Graduate School, Anna Maia College

Philip Malan, M.D., Ph.D., Professor of Anesthesiology and Pharmacology, Department of Medicine, University of Arizona